Latest News Archive

Please select Category, Year, and then Month to display items
Categories
UFS News Media Release Research
Years
2017 2018 2019 2020 2021 2022 2023 2024
Months
January February March April May June July August September October November December
Previous Archive
05 February 2018 Photo Johan Roux
Prof John Mubangizi appointed as UFS Dean of the Faculty of Law
Prof John Mubangizi.
The Council of the University of the Free State (UFS) approved the appointment of Prof John Mubangizi as Dean of the Faculty of Law during a meeting held on the Bloemfontein Campus on 22 January 2018. He assumed office on 1 February 2018.

“Prof Mubangizi’s extensive experience and scholarly contributions are most valuable to the university and the faculty, and I look forward to working with him,” says Prof Francis Petersen, Rector and Vice-Chancellor of the UFS.

Prof Mubangizi's academic qualifications include a Bachelor of Laws (LLB, Makerere University, Uganda), a Master’s in Public Law (LLM, University of Cape Town), and a Doctor of Laws (LLD, University of Durban-Westville). Prof Mubangizi also has several professional qualifications, including a Diploma in Education from Makerere University, and a Postgraduate Diploma in Legal Practice (Law Development Centre). He has been awarded several certificates in his area of academic specialisation, including a Certificate in Human Rights from the Institute of Human Rights (Strasbourg, France), and a Certificate in International Humanitarian Law from the Centre for Human Rights at the University of Pretoria.

He has been a full professor for more than twelve years. From January 2005 to April 2007, he served as Deputy Dean of the Faculty of Law at the University of KwaZulu-Natal (UKZN). From May 2007, he was Deputy Vice-Chancellor and Head of the College of Law and Management Studies at UKZN, with the responsibility of leading the academic and research strategy and realising the mandate of the college and the university.

One of the highlights of Prof Mubangizi’s research profile is the authorship of a book entitled The Protection of Human Rights in South Africa: A Legal and Practical Guide (2004 and 2013), which is widely used by scholars, practitioners, and students of human rights law in South Africa. He has published more than 60 publications, most of which are in SAPSE-accredited peer-reviewed journals. Furthermore, he has presented more than 40 academic papers at international conferences across the globe. He is rated by the National Research Foundation (NRF) as an established researcher.

Prof Mubangizi is a member of the Academy of Science of South Africa (ASSAf), and has served as member and advisor to the Council of ASSAf. He is currently the Chairperson of the Higher Education Quality Committee (HEQC) of South Africa, and a member of the Council on Higher Education (CHE). In addition, he serves on various committees and in different ad hoc positions at institutional, national, and international level.

News Archive

New research informs improved treatment of brain inflammation
2017-10-13

Description: Sebolai and Ogundeji Tags: Microbiologist, Dr Adepemi Ogundeji,  

Dr Adepemi Ogundeji, researcher in the Department of Microbial,
Biochemical and Food Biotechnology at the
University of the Free State,and Dr Olihile Sebolai,
her study leader from the same department.
Photo: Charl Devenish



Microbiologist Dr Adepemi Ogundeji has uncovered a new use for an old medicine that can potentially save lives and money. Under the guidance of her study leader, Dr Olihile Sebolai, Dr Ogundeji set out to fight a fungal disease caused by Cryptococcus neoformans. Drs Ogundeji and Sebolai are from the University of the Free State Department of Microbial, Biochemical and Food Biotechnology. 

Dr Ogundeji is passionate about education. “My aim will always be to transfer knowledge and skills in the microbiology field,” she said. “Dr Ogundeji’s study is celebrated in that it found a new purpose for existing medicines. An advantage of repositioning old medicines is by-passing clinical trials, which sometimes take 20 years, and the safety of such medicines is already known,” Dr Sebolai, explained.

Cryptococcus infections are difficult to control and often lead to brain inflammation. In layman’s terms: “Your brain is on fire”. People with HIV/Aids are especially vulnerable, surviving only about three months without treatment. Such patients may present with a Cryptococcus-emergent psychosis, and some with an out-of-control inflammatory condition when initiated on ARVs. 

Dr Ogundeji found that the clinically recommended dosage of aspirin (anti-inflammatory medicine), and quetiapine (anti-psychotic medicine) is sufficient to control the infection. Her exceptional work was readily published in some of the foremost journals in her field, namely, Antimicrobial Agents and Chemotherapy and Frontiers in Microbiology

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept